The Negative Correlation Between Testosterone Levels and Age in Healthy Indonesian Men Residing in The Special Capital Province of Jakarta, Indonesia by Parwanto, Edy ML
                                                        International Journal of Research in Medical Sciences | August 2017 | Vol 5 | Issue 8    Page 3431 
International Journal of Research in Medical Sciences 
Parwanto MLE. Int J Res Med Sci. 2017 Aug;5(8):3431-3437 
www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 
Original Research Article 
The negative correlation between testosterone levels and age in healthy 
Indonesian men residing in the special capital province of Jakarta, 
Indonesia 
Mauritius Lambertus Edy Parwanto* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Testosterone is a steroid hormone that functions in 
spermatogenesis. Production of testosterone under the 
control of the hypothalamic-pituitary-gonadal.1 
Production of testosterone is controlled by gonadotropin 
releasing hormone (GnRH), luteinizing hormone (LH) 
and follicle stimulating hormone (FSH). Production of 
FSH and LH stimulated by GnRH, so the tubulus 
seminiferous become mature.2,3 LH stimulates the Leydig 
cells to produce testosterone, while FSH stimulates the 
Sertoli cells to synthesize androgen binding protein 
(ABP).4,5 The function of ABP as testosterone transport 
from the interstitial tissues toward germinal epithelial cell 
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ABSTRACT 
 
Background: Testosterone levels in the circulation determined by production and secretion by Leydig cell in the 
testes. The action mechanism of testosterone to target cells mediated by sex hormone binding globulin (SHBG). The 
levels of testosterone and SHBG in circulation determine men's health. The objective in this study to know the 
relationship between testosterone, SHBG and insulin with age in healthy Indonesian men residing in the special 
capital province of Jakarta, Indonesia.  
Methods: This study is a cross-sectional study involving 250 healthy Indonesian men residing in the special capital 
province of Jakarta, Indonesia. Consecutive sampling was done in this study. Testosterone, SHBG and insulin in the 
serum were measured by immunoradiometric assay (IRMA). Glucose, triglycerides and albumin were measured using 
a spectrophotometer. Regression analysis was done to know the correlation between testosterone, SHBG and insulin 
with age. 
Results: The levels of TT, free testosterone (FT), SHBG and percentage of free testosterone (%FT) in healthy 
Indonesian men were negatively correlated with age (p<0.05). Free testosterone index (FTI) and insulin are not 
correlated with age (p>0.05). The levels of SHBG, FT, %FT and FTI were correlated positively with TT (p<0.05), but 
insulin did not correlate with TT (p>0.05). The %FT and FTI were positively correlated with FT (p<0.05), but SHBG 
and insulin levels did not correlate with FT (p>0.05). SHBG levels are not correlated with insulin (p>0.05). The rate 
of decline in TT levels in this study 9.8% per decade, while in SHBG levels 8.19% per decade.  
Conclusions: The levels of TT, FT, % FT and SHBG in this study were negatively correlated with age, but the FTI 
and insulin did not correlate with age. The rate of decline in TT levels in this study 9.8% per decade, while in SHBG 
levels 8.19% per decade.  
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through Sertoli cells. ABP also transported of 
testosterone to the epididymis.6 Furthermore, FSH 
production play an importance role to ABP production 
and indirect function regulation to the epididymis and 
sperm motility.7 
Testosterone intratesticular required for spermatogenesis. 
Testosterone excess for spermatogenesis to be secreted 
into the circulation system. Approximately 50% of 
circulating testosterone is bound to albumin, ± 44% 
bound to SHBG, ± 4% bound by cortisol-binding 
globulin (CBG), and ± 2% as free testosterone (FT). 
Circulating testosterone levels are often referred to as 
total testosterone (TT). Study result shows that TT levels 
in men decreases with increasing age.8 
FT levels in the circulation plays a key role in the 
negative feedback on the hypothalamus-pituitary-testes. 
FT levels in the circulation determined by LH levels. LH 
levels in the circulation directly determine testosterone 
secretion by testes.9 Only FT fraction that function in 
steroid action to target cells, including for bone and 
muscle growth.10-12 
Sex hormone binding globulin (SHBG) is a plasma 
glycoprotein synthesized by hepatocytes and also 
produced by the Sertoli cells.13,14 SHBG regulate 
androgen action and reversible with high affinity to 
androgens in circulation (DHT, testosterone, 3α-
androstenediol) and estrogen with lower affinity.13,15 In 
older men, increased of SHBG levels followed by 
decreased of FT levels, but TT levels did not change.16 
Study result shows that low levels of SHBG and 
testosterone in the circulation associated with metabolic 
syndrome.17 The changes of SHBG levels in the 
circulation can be caused by metabolic syndrome, 
overweight/obese and smoking habits.18-20 The other 
result showed that SHBG protein polymorphisms did not 
affect to the levels of SHBG, TT and FT.21 
Insulin produced by pancreatic cells and necessary for 
carbohydrate metabolism in the cells. Furthermore, it has 
been proven in men that increasing testosterone levels 
decreases insulin sensitivity.22 It has also been 
demonstrated in clinical trials that testosterone therapy 
decreases insulin resistance.23 Current study shows that 
insulin levels affected by SHBG protein polymorphism in 
healthy Indonesian men.21 
Recent research shows that the aging process results in an 
anabolic hormone defect, as resulting in lower physical 
activity and reduce the quality of nutrition.24 There is no 
research data about the correlation between testosterone 
and SHBG levels with age in healthy Indonesian men. 
We also do not know how the relationship between 
testosterone and SHBG levels with insulin. The general 
objective of this study to know the circumstances of the 
relationship between testosterone, SHBG and insulin 
levels with age in healthy Indonesian men residing in the 
special capital province of Jakarta, Indonesia.  
METHODS 
This study is a cross-sectional study involving 250 
healthy Indonesian men. All subjects assessed for 
eligibility. This study has obtained permission from the 
research ethics committee, faculty of medicine, university 
of Trisakti, Jakarta, Indonesia. All subjects gave written 
informed consent before following this study. 
Subjects in this study are healthy Indonesian men 
residing in the special capital province of Jakarta (East 
Jakarta, North Jakarta, West Jakarta, South Jakarta or 
Central Jakarta), Indonesia. Sampling was done by 
consecutive sampling. Two hundred and fifty subjects 
who met the inclusion criteria. Inclusion criteria include 
healthy Indonesian men according to physical 
examination performed by a physician, 31-60 years of 
age, and at least one child. Blood sample collection was 
conducted in January-September 2013. The levels of 
fasting blood glucose 70-105 mg/dL, triglyceride 40-160 
mg/dL, and albumin 3.5-5.3 mg/dL. Exclusion criteria 
include liver cirrhosis, hypergonadal, hypogonadal, 
diabetes, medications that affect to liver function, SHBG 
levels, steroid and insulin levels. Subjects were excluded 
if who were not present during the retrieval of research 
data. Data subjects were not included in the analysis if a 
blood sample lysis. 
Fasting blood collection for all subjects was done in the 
morning. Ten milliliters of blood were taken from the 
cubital vein. Serum isolation from blood sample was 
done by centrifugation at 3000 revolutions per minute 
(rpm) for 20 minutes. Serum is stored at -20 °C. 
Measurement of SHBG, TT, FT, insulin, glucose, 
triglyceride and albumin levels in the serum was done at 
the Laboratory of Endocrinology, Faculty of Medicine, 
University of Indonesia. 
Hormone levels measurement such as TT, FT, SHBG and 
insulin by radioimmunoassay (IRMA). Hormone levels 
measurement was done in duplicate. We used Coat-A-
Count TT to measure TT, Coat-A-Count FT to measure 
FT, IRMA-Count SHBG to measure SHBG and Coat-A-
Count Insulin reagents to measure insulin levels in the 
serum. Reagents are produced by DPC: 5210 Pacific 
Concourse Drive, Los Angeles, California 90045, USA). 
Coefficient of variation (intra-assay and inter-assay) and 
sensitivity in the value of acceptance criteria. 
Measurement of glucose, triglyceride and albumin levels 
was done by enzymatic. Glucose-hexokinase reagent was 
used to measure glucose, while triglyceride-GPO reagent 
to measure triglyceride and albumin reagent was used to 
measure albumin. The third type of reagent made by 
Chiron Diagnostics GmbH, Siemens Strasse 3, D-35 463 
Fernwald, Germany). Spectrophotometer SEAC CH 100 
was used to measure the levels of these substances. 
Precision, accuracy and deviation of measurements in the 
value of acceptance criteria. 
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The %FT was calculated using the formula {(FT/TT) x 
100%}, whereas the FTI was calculated using the formula 
{(TT/SHBG) x 100}. 
Statistical analysis 
Regression analysis was used to determine the 
relationship between age, SHBG, TT, FT, %FT, FTI and 
insulin. 
RESULTS 
Subjects in this study are 250 healthy Indonesian men, 
31-60 years of age. Characteristics of the subjects are 
presented in Table 1. 
Table 1: Characteristics of the subjects. 
Variable Mean±SD 
Age (years) 46.2±8.71 
BMI (kg/m2) 22.93±4.25  
Glucose (mg/dL) 90.86±8.63  
Triglyceride (mg/dL) 102.01±9.26  
Albumin (mg/dL) 4.30±0.12  
Abbreviations: SD = standard of deviation, BMI = body mass 
index, kg/m2 = kilogram per meter square, mg/dL = 
milligrams per decilitre. 
Correlation between SHBG, TT, FT, % FT, FTI and 
insulin with age are presented in Table 2. 
 
Table 2: Correlations between SHBG, TT, FT, % FT, FTI and insulin with age. 
 Regression equation p value R  R2  
SHBG (nmol/L)  = 48.849 – (0.328*age) 0.000 0.312 0.097 
TT (nmol/L)  = 28.827 – (0.224*age) 0.000 0.424 0.180 
FT (nmol/L)  = 0.088 – (0.001*age) 0.000  0.341 0.116 
%FT (%)  = 0.275 + (0.002*age) 0.027 0.190 0.036 
FTI  = 62.117 – (0.105*age) 0.483 0.061 0.055 
Insulin (μIU/mL)  = 7.994 – (0.018*age) 0.492 0.060 0.004 
SHBG (nmol/L)  = 18.988 + (0.802*TT) 0.000 0.404 0.163 
FT (nmol/L)  = 0.036 + (0.001*TT) 0.000 0.505 0.255 
%FT (%)  = 0.560 + (0.011*TT) 0.000 0.621 0.386 
FTI  = 27.409 + (1.607*TT) 0.000 0.495 0.245 
Insulin (μIU/mL)  = 8.942 – (0.094*TT) 0.052 0.168 0.028 
SHBG (nmol/L)  = 27.955 + (93.905*FT) 0.113 0.138 0.019 
%FT (%)  = 0.228 + (2.002*FT) 0.000 0.331 0.110 
FTI  = 33.775 + (369.639*FT) 0.000 0.332 0.110 
Insulin (μIU/mL)  = 8.700 – (23.715*FT) 0.156 0.123 0.015 
SHBG (nmol/L)  = 36.633 – (0.374*INS) 0.225 0.105 0.011 
Abbreviations: SHBG = sex hormone binding globulin, TT = total testosterone, FT = free testosterone; %FT = the percentage of free 
testosterone, FTI = free testosterone index. nmol/L = nano mol per liter, μIU/mL = micron international units per millilitre. 
 
SHBG, TT, FT and %FT levels were negatively 
correlated with age (p<0.05), whereas FTI and insulin 
levels were not correlated with age (p>0.05). SHBG, FT, 
%FT and FTI levels were positively correlated with TT 
(p<0.05), whereas insulin levels did not correlate with TT 
(p>0.05). The %FT and FTI were positively correlated 
with FT (p<0.05), whereas SHBG and insulin were not 
correlate with FT (p>0.05). The levels of SHBG are not 
correlated with insulin (p>0.05). 
DISCUSSION 
Referring to normal value of TT levels used by Kapoor et 
al, i.e. 8.3-41.6 nmol/L, then the average of TT levels in 
this study 18.63±0.81 nmol/L (Mean±SD) was normal.25 
Other researchers used normal value of the TT levels 8.8-
31.2 nmol/L.26 The other result of my study in normal 
SHBG phenotype showed that TT levels 18.80±5.64 
nmol/L, while in variant SHBG phenotype 20.31±6.86 
nmol/L.21 Moreover, study of European men showed that 
average of TT levels 15.8 nmol/L (95% CI: 15.2-16.3 
nmol/L).20 Based on the data, the average of TT levels in 
European men was lower than Indonesian men. The 
differences in the TT levels due to ethnic variation, 
dietary intake and lifestyle.27  
According to the guidelines used by Baisley et al, the 
average levels of FT in this study 0.063 ± 0.0013 nmol/L 
is included in the range of normal values.28 The other 
result of my study in normal SHBG phenotype showed 
that FT levels 0.065±0.01 nmol/L, while in variant SHBG 
phenotype 0.064±0.77 nmol/L.21 The results of this study 
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indicate that the decrease in TT levels followed by a 
decrease in FT levels, so FT correlates positively with 
TT. The fact is understandable because the level of FT 
depends on the production of TT. It is also known that FT 
has the function of negative feedback and autoregulation 
to hypothalamus and pituitary.29 We know that negative 
feedback mechanism is an important regulation of 
hormone levels in the circulation. 
This study shows that the levels of TT and FT were 
negatively correlated with age. The other study also 
obtained the same results with this study that increasing 
age was followed by a decrease in the levels of TT.17,30 
The negative correlation between FT and age also 
obtained the same results earlier.31,32 Compared to 
Canadian men, the decrease of TT levels in this study 
was lower. Decreases of TT levels in Canadian men 10-
17% per decade, whereas in this study only 9.8% per 
decade.33 Results of another study showed that decreases 
of TT levels in European men only 2.15% per decade.22 
Results of this study are also consistent with other studies 
showing that TT levels in adult men is higher than in 
older men.34 This further reinforces the fact that the 
increasing age decreases the levels of TT. Further 
research in Australia showed that men 70-89 years of age 
had an average level of TT 15.4 ± 5.6 nmol/L (444 ± 162 
ng/dL) was lower than Australian men less than 70 years 
of age. In addition, the Australian men ≥70 years of age 
had a level were low, but still within the range of normal 
values.23 
Changes in TT levels have been shown by previous 
researchers.16,35 The previous study showed that in 
Australian men 70-89 years of age decrease in TB levels, 
but TT levels did not change and SHBG levels 
increased.16 The difference of changes in the levels of TT 
and FT in this study compared to the study in Australia 
were caused by differences in the age of the respondent. 
There are other possibilities that cause these differences, 
for example smoking habits conducted by the respondent. 
We cannot control to this habit. Study of the smoking 
effect on FT levels was done in 7 European countries. 
The result showed that the levels of FT among smokers 
was higher than non-smokers.20 Recent studies in men 
also shown that testosterone levels in smokers was higher 
than non-smokers.36 These results are also consistent with 
studies showing the variation of FT levels in healthy 
adult males.37 
The average levels of SHBG in this study 34.01±1.53 
nmol/L. Based on the normal value of SHBG levels are 
used as guidelines by Lopez et al, the levels of SHBG in 
this study are included in the range of normal values.30 
SHBG levels in this study correlated negatively with age. 
The other result of my study showed that SHBG levels in 
normal SHBG phenotype 31.70±13.78 nmol/L, while in 
variant SHBG phenotype 37.69±16.17 nmol/L.21 
Research conducted by Lapauw et al, also obtained 
comparable results with this study.31 The results of 
another study in Brazil showed that SHBG levels 
correlated positively with age. Differences on these 
results dues to differences in the age of the subject. The 
age of the subjects in this study 31-60 years, while in 
Brasilia 50-80 years. In Brazilian men 50-80 years of age 
showed increased levels of SHBG every decade.30 
Present study results suggest that SHBG levels decreased 
8.19% every decade.  
Result in this study shown that SHBG levels correlated 
positively with TT, but not correlated with FT. The 
positive correlation between SHBG with TT in 
accordance with the results of previous studies.16 Our 
data suggest that SHBG synthesis by hepatocytes in 
syncrone with the production of testosterone by the 
Leydig cells. We found a positive correlation between 
SHBG and TT in healthy Indonesian men determined by 
the levels of glucose, triglyceride and albumin in the 
circulation. Results of other studies on diabetic men 
showed that TT and SHBG levels are low.38 The other 
study showed that low TT levels result in high fasting 
blood glucose levels.39 It also has been demonstrated a 
positive correlation between SHBG and TT. In diabetic 
men, the first year has a TT and SHBG levels was lower 
than normal men, but in older men who have diabetes 
increased TT and SHBG levels. This result caused by 
decrease in the availability of testosterone (bioavailable 
testosterone = BioT).40 Furthermore, results of other 
studies on obese men showed that the decline in testicular 
function so that the TT and SHBG levels decreased, 
resulting effect on spermatogenesis. Many factors affect 
the levels of testosterone and SHBG. TT and SHBG had 
a significant negative correlation with fasting blood 
glucose level.39 Results of other studies also showed that 
the levels of TT were lower in men with metabolic 
syndrome, but the levels of FT and SHBG were not 
different between men with metabolic syndrome 
compared to normal men.41 In the front has been stated 
that TT levels among others influenced by nutritional 
factors.27 In addition, it has been shown that nutritional 
factors also affected to SHBG levels in men and 
women.42,43 
The average of FTI in this study 54.78. Based on the 
guidelines used by Ly and Handelsman, FTI in this study 
are included in the range of normal values.44 FTI in this 
study did not correlate with age. Based on these data can 
be presumed that the bond between testosterone and 
SHBG are normal. Results of another study in men 50-80 
years of age showed a decline FTI every decade.30 
The average of %FT in this study 0.34%. Results of this 
study showed that the %FT within the range of normal 
values and positively correlated with age. The %FT is 
also positively correlated to TT and FT. The %FT in this 
study 0.35 ± 0.01%. The result study by Ronde et al, 
showed that the %FT 1.09 to 3.09, thus higher than the 
results of this study. The other result of study showed that 
the %FT 0.86-1.91%, thus higher than in this study.45,46 
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Insulin levels in this study 7.18±0.39 μIU/mL. Guidelines 
for the normal value of fasting insulin levels 6-27 
μIU/mL.47 Based on the guidelines used by the level of 
insulin in this study are included in the range of normal 
values. In this study, insulin levels did not correlate with 
age. Insulin also not correlated with TT, FT and SHBG. 
The other hand showed that insulin levels in men with 
variant SHBG phenotype was higher than normal SHBG 
phenotype.21 This fact reinforces that genetic factors 
affect to insulin levels in the circulation. This is a 
limitation of the study because it was not done 
phenotyping of SHBG. Futhermore, in the pathological 
conditions, insulin resistance in men negatively 
correlated with testosterone.48-51 The different results 
proved that bioavailable testosterone, TT, FT and SHBG 
were positively correlated with fasting insulin.49 The 
results of another study showed that insulin secretion, 
insulin clearance and interaction of insulin with target 
cells defective in further age.52 
CONCLUSION 
Base on this data we concluded that the levels of TT, FT 
and SHBG were negatively correlated with age, but the 
%FT positively correlated with age, while FTI and 
insulin are not correlated with age. TT levels positively 
correlated with SHBG, FT, %FT and FTI, but not 
correlated with insulin. The levels of FT positively 
correlated with FTI and %FT, but not correlated with 
SHBG and insulin. The levels of SHBG are not correlated 
with insulin. The rate of decrease in TT levels in this 
study 9.8% per decade, while in SHBG levels 8.19% per 
decade. 
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